Inside the Factory Supplying Half of Africa’s Syringes
The New York Times
In Kenya, Revital Healthcare is manufacturing medical products that Africa needs to take charge of routine health care and respond to outbreaks.
On the stunning Kenyan coast, about halfway between 15th-century ruins and the vibrant city of Mombasa, a small factory is helping to achieve one of Africa’s biggest health care goals: self-reliance.
With fewer than 700 employees, Revital Healthcare makes 300 million syringes a year, enough to meet more than half of Africa’s routine immunization needs.
In the throes of the coronavirus pandemic, when governments were faced with vaccinating millions of people amid severe shortages, Revital shipped syringes to Sri Lanka, Sweden, the United Arab Emirates and Uzbekistan — and even sent 15 million syringes to India, said Roneek Vora, the company’s director of sales and marketing.
“This is the first time ever in the life of Africa that a medical industry is exporting syringes to India, when we know India is a powerhouse of syringe manufacturing,” Mr. Vora said. “This was a very big deal for us — it broke a lot of barriers,” he added.
Revital is richly funded through grants and contracts from many donor organizations, including the U.S. Agency for International Development, the Save the Children Foundation and multiple arms of the United Nations, and the company has lofty ambitions.
Many of Africa’s attempts at medical self-reliance have been hampered by limited funds, the lack of a robust regulatory system and the challenges in transporting drugs and vaccines. Against that backdrop, Revital’s success offers hope that an African company can manufacture essential products — not just for the continent, but also for export to other countries.
For a century, exoplanet hunters have “discovered” planets around a nearby star, only to retract the claims. But the latest find is for real.
The unidentified patient had recently returned from Africa, where the virus has caused a deadly epidemic, health officials said.
The event produces some of the year’s fastest meteors, although the nearly full moon may make them challenging to spot.
Mr. Musk dug into his companies’ budgets, preferring to cut too much rather than too little and to deal with the fallout later. Under Donald Trump, he is set to apply those tactics to the U.S. government.
Behind the scenes at a Chicago zoo, chimpanzees who spent years entertaining humans are learning to befriend their own kind.
The agency’s top medical official was responding to rumors that Suni Williams had lost an unusual amount of weight during an extended stay in orbit.
Artificial intelligence has become a subject for people in the art and theater worlds who are worried about being replaced by it.
President-elect Trump says tariffs will help American businesses, but many in the wine industry foresee few benefits and a lot of pain for all involved.
Ball pythons were long assumed to be solitary, but scientists discovered the snakes in captivity prefer each others’ company when given the chance to live socially.
The Justice Department and four Democratic state attorneys general argued that United’s takeover would limit competition and harm consumers needing home or hospice care.
It took nearly 25 years for biologists to discover that a swimming and glowing organism in the ocean’s midnight zone was actually a sea slug.